Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Glycogenin 1 anticorps (AA 251-350) (Cy5)

GYG1 Reactivité: Humain IF (cc), IF (p) Hôte: Lapin Polyclonal Cy5
N° du produit ABIN1704673
  • Antigène Voir toutes Glycogenin 1 (GYG1) Anticorps
    Glycogenin 1 (GYG1)
    Épitope
    • 16
    • 3
    • 3
    • 1
    • 1
    • 1
    • 1
    AA 251-350
    Reactivité
    • 28
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 23
    • 5
    Lapin
    Clonalité
    • 25
    • 3
    Polyclonal
    Conjugué
    • 14
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp Glycogenin 1 est conjugé à/à la Cy5
    Application
    • 27
    • 14
    • 14
    • 10
    • 7
    • 4
    • 2
    • 1
    • 1
    Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
    Homologie
    Human,Mouse,Rat,Dog,Cow,Sheep
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human Glycogenin 1
    Isotype
    IgG
    Top Product
    Discover our top product GYG1 Anticorps primaire
  • Indications d'application
    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Date de péremption
    12 months
  • Antigène
    Glycogenin 1 (GYG1)
    Autre désignation
    Glycogenin 1 (GYG1 Produits)
    Synonymes
    anticorps GSD15, anticorps GYG, anticorps Gyg, anticorps gyg, anticorps fc13d04, anticorps fi23f07, anticorps gyg1, anticorps wu:fc13d04, anticorps wu:fi23f07, anticorps zgc:55385, anticorps zgc:85619, anticorps glycogenin-1, anticorps MGC79098, anticorps GYG1, anticorps glycogenin 1, anticorps glycogenin 1a, anticorps glycogenin 1 S homeolog, anticorps GYG1, anticorps Gyg1, anticorps gyg1, anticorps gyg1a, anticorps gyg1.S
    Sujet

    Synonyms: Glycogenin, Glycogenin-1, Glycogenin1, GLYG_HUMAN, GN-1, GN1, GYG 1, GYG, GYG1.

    Background: Glycogen synthesis is initiated by the autoglucosylation of Glycogenin-1. Specifically, Glycogenin-1 glucosylates itself to begin the synthesis of glycogen in mammalian skeletal muscle. It acts as the primer to which further glucose monomers may be added. All of the Glycogenin-1 Molecules contain at least one glucosyl residue before autoglucosylation begins. The first step of the glycogen synthesis occurs when a glucose molecule from UDP-glucose binds to the hydroxyl group of Tyr 194 on the Glycogenin-1 Molecule. Using its glucosyltransferase activity, Glycogenin-1 adds more glucoses, each one coming from UDP-glucose. The glycosylation process reaches a plateau when five new glucose residues have been added, at which point glycogen synthase (GS) takes over and further elongates the chain. Glycogenin-1 remains covalently attached to the reducing end of the glycogen molecule.

    Pathways
    Cellular Glucan Metabolic Process
Vous êtes ici:
Support technique